APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fosfomycin Sodium

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Fosfomycin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchFosfomycin Sodium Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Fosfomycin Sodium Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Fosfomycin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fosfomycin Sodium Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Fosfomycin Sodium Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Fosfomycin Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fosfomycin Sodium include New Asia Pharma, Dorrapharma, Merck KGaA, FarmaSino Pharmaceutical, Hubei Xunda Pharmaceutical, Northeast Pharma, Sundent Pharm Group, Shin Poong Pharm and National Analytical Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fosfomycin Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fosfomycin Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fosfomycin Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fosfomycin Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Fosfomycin Sodium Segment by Company

New Asia Pharma

Dorrapharma

Merck KGaA

FarmaSino Pharmaceutical

Hubei Xunda Pharmaceutical

Northeast Pharma

Sundent Pharm Group

Shin Poong Pharm

National Analytical Corporation

Ercros

Fosfomycin Sodium Segment by Type

Tablets

Injection

Fosfomycin Sodium Segment by Application

Hospital

Clinic

Other

Fosfomycin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fosfomycin Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fosfomycin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fosfomycin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fosfomycin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fosfomycin Sodium Industry Trends Table 2. Fosfomycin Sodium Industry Drivers Table 3. Fosfomycin Sodium Industry Opportunities and Challenges Table 4. Fosfomycin Sodium Industry Restraints Table 5. Global Fosfomycin Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fosfomycin Sodium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fosfomycin Sodium Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Fosfomycin Sodium Sales Market Share by Manufacturers Table 9. Global Fosfomycin Sodium Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Fosfomycin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fosfomycin Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fosfomycin Sodium Manufacturers, Product Type & Application Table 13. Global Fosfomycin Sodium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fosfomycin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Injection Table 18. Global Fosfomycin Sodium Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Fosfomycin Sodium Sales by Type (2021-2026) & (k units) Table 20. Global Fosfomycin Sodium Sales by Type (2027-2032) & (k units) Table 21. Global Fosfomycin Sodium Sales Market Share by Type (2021-2026) Table 22. Global Fosfomycin Sodium Sales Market Share by Type (2027-2032) Table 23. Global Fosfomycin Sodium Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Fosfomycin Sodium Revenue by Type (2021-2026) & (k units) Table 25. Global Fosfomycin Sodium Revenue by Type (2027-2032) & (k units) Table 26. Global Fosfomycin Sodium Revenue Market Share by Type (2021-2026) Table 27. Global Fosfomycin Sodium Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Fosfomycin Sodium Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Fosfomycin Sodium Sales by Application (2021-2026) & (k units) Table 33. Global Fosfomycin Sodium Sales by Application (2027-2032) & (k units) Table 34. Global Fosfomycin Sodium Sales Market Share by Application (2021-2026) Table 35. Global Fosfomycin Sodium Sales Market Share by Application (2027-2032) Table 36. Global Fosfomycin Sodium Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Fosfomycin Sodium Revenue by Application (2021-2026) & (k units) Table 38. Global Fosfomycin Sodium Revenue by Application (2027-2032) & (k units) Table 39. Global Fosfomycin Sodium Revenue Market Share by Application (2021-2026) Table 40. Global Fosfomycin Sodium Revenue Market Share by Application (2027-2032) Table 41. Global Fosfomycin Sodium Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Fosfomycin Sodium Sales by Region (2021-2026) & (k units) Table 43. Global Fosfomycin Sodium Sales Market Share by Region (2021-2026) Table 44. Global Fosfomycin Sodium Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Fosfomycin Sodium Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Fosfomycin Sodium Sales by Country (2021-2026) & (k units) Table 48. North America Fosfomycin Sodium Sales by Country (2027-2032) & (k units) Table 49. Europe Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Fosfomycin Sodium Sales by Country (2021-2026) & (k units) Table 51. Europe Fosfomycin Sodium Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Fosfomycin Sodium Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Fosfomycin Sodium Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Fosfomycin Sodium Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Fosfomycin Sodium Sales by Country (2027-2032) & (k units) Table 58. Global Fosfomycin Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Fosfomycin Sodium Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Fosfomycin Sodium Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Fosfomycin Sodium Revenue Market Share by Region (2021-2026) Table 62. Global Fosfomycin Sodium Revenue Market Share by Region (2027-2032) Table 63. New Asia Pharma Company Information Table 64. New Asia Pharma Business Overview Table 65. New Asia Pharma Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. New Asia Pharma Fosfomycin Sodium Product Portfolio Table 67. New Asia Pharma Recent Development Table 68. Dorrapharma Company Information Table 69. Dorrapharma Business Overview Table 70. Dorrapharma Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Dorrapharma Fosfomycin Sodium Product Portfolio Table 72. Dorrapharma Recent Development Table 73. Merck KGaA Company Information Table 74. Merck KGaA Business Overview Table 75. Merck KGaA Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck KGaA Fosfomycin Sodium Product Portfolio Table 77. Merck KGaA Recent Development Table 78. FarmaSino Pharmaceutical Company Information Table 79. FarmaSino Pharmaceutical Business Overview Table 80. FarmaSino Pharmaceutical Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. FarmaSino Pharmaceutical Fosfomycin Sodium Product Portfolio Table 82. FarmaSino Pharmaceutical Recent Development Table 83. Hubei Xunda Pharmaceutical Company Information Table 84. Hubei Xunda Pharmaceutical Business Overview Table 85. Hubei Xunda Pharmaceutical Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hubei Xunda Pharmaceutical Fosfomycin Sodium Product Portfolio Table 87. Hubei Xunda Pharmaceutical Recent Development Table 88. Northeast Pharma Company Information Table 89. Northeast Pharma Business Overview Table 90. Northeast Pharma Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Northeast Pharma Fosfomycin Sodium Product Portfolio Table 92. Northeast Pharma Recent Development Table 93. Sundent Pharm Group Company Information Table 94. Sundent Pharm Group Business Overview Table 95. Sundent Pharm Group Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sundent Pharm Group Fosfomycin Sodium Product Portfolio Table 97. Sundent Pharm Group Recent Development Table 98. Shin Poong Pharm Company Information Table 99. Shin Poong Pharm Business Overview Table 100. Shin Poong Pharm Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shin Poong Pharm Fosfomycin Sodium Product Portfolio Table 102. Shin Poong Pharm Recent Development Table 103. National Analytical Corporation Company Information Table 104. National Analytical Corporation Business Overview Table 105. National Analytical Corporation Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. National Analytical Corporation Fosfomycin Sodium Product Portfolio Table 107. National Analytical Corporation Recent Development Table 108. Ercros Company Information Table 109. Ercros Business Overview Table 110. Ercros Fosfomycin Sodium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Ercros Fosfomycin Sodium Product Portfolio Table 112. Ercros Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Fosfomycin Sodium Distributors List Table 116. Fosfomycin Sodium Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Fosfomycin Sodium Product Image Figure 2. Global Fosfomycin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fosfomycin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Fosfomycin Sodium Sales (2021-2032) & (k units) Figure 5. Global Fosfomycin Sodium Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Fosfomycin Sodium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Injection Image Figure 10. Global Fosfomycin Sodium Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Fosfomycin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Fosfomycin Sodium Sales Market Share by Type (2021-2032) Figure 13. Global Fosfomycin Sodium Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Fosfomycin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Fosfomycin Sodium Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Fosfomycin Sodium Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Fosfomycin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Fosfomycin Sodium Sales Market Share by Application (2021-2032) Figure 22. Global Fosfomycin Sodium Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Fosfomycin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Fosfomycin Sodium Revenue Market Share by Application (2021-2032) Figure 25. North America Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Fosfomycin Sodium Sales Market Share by Country (2021-2032) Figure 27. U.S. Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Fosfomycin Sodium Sales Market Share by Country (2021-2032) Figure 32. Germany Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Fosfomycin Sodium Sales Market Share by Country (2021-2032) Figure 39. China Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Fosfomycin Sodium Sales Market Share by Country (2021-2032) Figure 47. Brazil Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Fosfomycin Sodium Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Fosfomycin Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Fosfomycin Sodium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Fosfomycin Sodium Revenue (2021-2032) & (US$ Million) Figure 58. North America Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Fosfomycin Sodium Revenue (2021-2032) & (US$ Million) Figure 60. Europe Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Fosfomycin Sodium Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Fosfomycin Sodium Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Fosfomycin Sodium Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Fosfomycin Sodium Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injection
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • New Asia Pharma
  • Dorrapharma
  • Merck KGaA
  • FarmaSino Pharmaceutical
  • Hubei Xunda Pharmaceutical
  • Northeast Pharma
  • Sundent Pharm Group
  • Shin Poong Pharm
  • National Analytical Corporation
  • Ercros

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fosfomycin Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fosfomycin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fosfomycin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fosfomycin Sodium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fosfomycin Sodium Market Dynamics
  1. 2.1 Fosfomycin Sodium Industry Trends
  2. 2.2 Fosfomycin Sodium Industry Drivers
  3. 2.3 Fosfomycin Sodium Industry Opportunities and Challenges
  4. 2.4 Fosfomycin Sodium Industry Restraints
3 Fosfomycin Sodium Market by Manufacturers
  1. 3.1 Global Fosfomycin Sodium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fosfomycin Sodium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fosfomycin Sodium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fosfomycin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fosfomycin Sodium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fosfomycin Sodium Manufacturers, Product Type & Application
  7. 3.7 Global Fosfomycin Sodium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fosfomycin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fosfomycin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fosfomycin Sodium Tier 1, Tier 2, and Tier 3
4 Fosfomycin Sodium Market by Type
  1. 4.1 Fosfomycin Sodium Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injection
  4. 4.2 Global Fosfomycin Sodium Sales by Type
  5. 4.2.1 Global Fosfomycin Sodium Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fosfomycin Sodium Sales by Type (2021-2032)
  7. 4.2.3 Global Fosfomycin Sodium Sales Market Share by Type (2021-2032)
  8. 4.3 Global Fosfomycin Sodium Revenue by Type
  9. 4.3.1 Global Fosfomycin Sodium Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fosfomycin Sodium Revenue by Type (2021-2032)
  11. 4.3.3 Global Fosfomycin Sodium Revenue Market Share by Type (2021-2032)
5 Fosfomycin Sodium Market by Application
  1. 5.1 Fosfomycin Sodium Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Fosfomycin Sodium Sales by Application
  6. 5.2.1 Global Fosfomycin Sodium Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fosfomycin Sodium Sales by Application (2021-2032)
  8. 5.2.3 Global Fosfomycin Sodium Sales Market Share by Application (2021-2032)
  9. 5.3 Global Fosfomycin Sodium Revenue by Application
  10. 5.3.1 Global Fosfomycin Sodium Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fosfomycin Sodium Revenue by Application (2021-2032)
  12. 5.3.3 Global Fosfomycin Sodium Revenue Market Share by Application (2021-2032)
6 Global Fosfomycin Sodium Sales by Region
  1. 6.1 Global Fosfomycin Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fosfomycin Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Fosfomycin Sodium Sales by Region (2021-2026)
  4. 6.2.2 Global Fosfomycin Sodium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fosfomycin Sodium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fosfomycin Sodium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fosfomycin Sodium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fosfomycin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fosfomycin Sodium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fosfomycin Sodium Revenue by Region
  1. 7.1 Global Fosfomycin Sodium Revenue by Region
  2. 7.1.1 Global Fosfomycin Sodium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fosfomycin Sodium Revenue by Region (2021-2026)
  4. 7.1.3 Global Fosfomycin Sodium Revenue by Region (2027-2032)
  5. 7.1.4 Global Fosfomycin Sodium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fosfomycin Sodium Revenue (2021-2032)
  8. 7.2.2 North America Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fosfomycin Sodium Revenue (2021-2032)
  11. 7.3.2 Europe Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fosfomycin Sodium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fosfomycin Sodium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fosfomycin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 New Asia Pharma
  2. 8.1.1 New Asia Pharma Company Information
  3. 8.1.2 New Asia Pharma Business Overview
  4. 8.1.3 New Asia Pharma Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 New Asia Pharma Fosfomycin Sodium Product Portfolio
  6. 8.1.5 New Asia Pharma Recent Developments
  7. 8.2 Dorrapharma
  8. 8.2.1 Dorrapharma Company Information
  9. 8.2.2 Dorrapharma Business Overview
  10. 8.2.3 Dorrapharma Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dorrapharma Fosfomycin Sodium Product Portfolio
  12. 8.2.5 Dorrapharma Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Fosfomycin Sodium Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 FarmaSino Pharmaceutical
  20. 8.4.1 FarmaSino Pharmaceutical Company Information
  21. 8.4.2 FarmaSino Pharmaceutical Business Overview
  22. 8.4.3 FarmaSino Pharmaceutical Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 FarmaSino Pharmaceutical Fosfomycin Sodium Product Portfolio
  24. 8.4.5 FarmaSino Pharmaceutical Recent Developments
  25. 8.5 Hubei Xunda Pharmaceutical
  26. 8.5.1 Hubei Xunda Pharmaceutical Company Information
  27. 8.5.2 Hubei Xunda Pharmaceutical Business Overview
  28. 8.5.3 Hubei Xunda Pharmaceutical Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Xunda Pharmaceutical Fosfomycin Sodium Product Portfolio
  30. 8.5.5 Hubei Xunda Pharmaceutical Recent Developments
  31. 8.6 Northeast Pharma
  32. 8.6.1 Northeast Pharma Company Information
  33. 8.6.2 Northeast Pharma Business Overview
  34. 8.6.3 Northeast Pharma Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Northeast Pharma Fosfomycin Sodium Product Portfolio
  36. 8.6.5 Northeast Pharma Recent Developments
  37. 8.7 Sundent Pharm Group
  38. 8.7.1 Sundent Pharm Group Company Information
  39. 8.7.2 Sundent Pharm Group Business Overview
  40. 8.7.3 Sundent Pharm Group Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sundent Pharm Group Fosfomycin Sodium Product Portfolio
  42. 8.7.5 Sundent Pharm Group Recent Developments
  43. 8.8 Shin Poong Pharm
  44. 8.8.1 Shin Poong Pharm Company Information
  45. 8.8.2 Shin Poong Pharm Business Overview
  46. 8.8.3 Shin Poong Pharm Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shin Poong Pharm Fosfomycin Sodium Product Portfolio
  48. 8.8.5 Shin Poong Pharm Recent Developments
  49. 8.9 National Analytical Corporation
  50. 8.9.1 National Analytical Corporation Company Information
  51. 8.9.2 National Analytical Corporation Business Overview
  52. 8.9.3 National Analytical Corporation Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 National Analytical Corporation Fosfomycin Sodium Product Portfolio
  54. 8.9.5 National Analytical Corporation Recent Developments
  55. 8.10 Ercros
  56. 8.10.1 Ercros Company Information
  57. 8.10.2 Ercros Business Overview
  58. 8.10.3 Ercros Fosfomycin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ercros Fosfomycin Sodium Product Portfolio
  60. 8.10.5 Ercros Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fosfomycin Sodium Value Chain Analysis
  2. 9.1.1 Fosfomycin Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fosfomycin Sodium Production Mode & Process
  6. 9.2 Fosfomycin Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fosfomycin Sodium Distributors
  9. 9.2.3 Fosfomycin Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst